- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04263649
Prospective Observational Study of the Power PICC Family of Devices and Accessories
March 17, 2022 updated by: Becton, Dickinson and Company
Post-market, observational study to collect prospective data related to the safety and performance of the Power PICC family of devices and its accessories in a real-world setting.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Single-arm, post-market, observational, prospective study to asses the safety and performance of the Power PICC Power PICC family of devices and its accessories in a real-world setting.
The study will only enroll patients that need a Power PICC catheter as part of their medical care.
Patients will be followed from insertion through removal, or up to 180 days (whichever comes first).
Data collected will be gathered from the patient's medical chart.
Study Type
Observational
Enrollment (Actual)
450
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Klagenfurt, Austria
- Klinikum Klagenfurt
-
Vienna, Austria, A-1090
- Medizinische Universität Wien
-
-
-
-
-
Leuven, Belgium, B-3000
- University Hospitals KU Leuven
-
-
-
-
-
Olomouc, Czechia
- Fakultní nemocnice Olomouc
-
-
-
-
-
Sønderborg, Denmark, 6400
- Sygehus Soenderjylland, Sønderborg
-
-
-
-
-
Jena, Germany
- Universitätsklinikum Jena
-
-
-
-
-
Napoli, Italy
- Azienda Ospedaliera dei Colli - Monaldi
-
-
Piedmont
-
Alessandria, Piedmont, Italy, 15121
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo
-
Turin, Piedmont, Italy, 10126
- A.O.U Città della Salute e della Scienza Torino, Ospedale Molinette
-
-
Piemonte
-
Ivrea, Piemonte, Italy, 10015
- Ospedale Civile di Ivrea
-
-
Trentino
-
Bolzano, Trentino, Italy, 39100
- Ospedale Centrale di Bolzano
-
-
-
-
-
Den Haag, Netherlands, 2545
- Haga ziekenhuis
-
-
-
-
-
Girona, Spain
- Hospital Universitari de Girona Dr Josep Trueta
-
-
-
-
-
Zürich, Switzerland, 8091
- Institut für diagnostische und interventionelle Radiologie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Any patients who require a PICC device in a primary care facility.
Description
Inclusion Criteria:
- Any patient, regardless of age or gender, for which the investigator has decided that one of the PowerPICC study devices for either short-or long-term venous access should be inserted as standard of care
- Expected to be available for observation through the duration of PICC therapy (including outpatient therapy, if applicable)
- Provision of signed and dated informed consent form (Note: Consent of guardian or parent may be required for patients under the age of 18 years; participant assent may be required as well.)
Exclusion Criteria:
- Presence of any device-related infection, bacteremia, or septicemia is known or suspected
- Body size is insufficient to accommodate the size of implanted device
- Known or suspected to be allergic to materials contained in the device
- History of irradiation of prospective insertion site
- Previous episode(s) of venous thrombosis or vascular surgical procedures at the prospective placement site
- Local tissue factors which would prevent proper device stabilization and/or access
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
All subjects
patients who require a PICC
|
insertion of a Peripherally Inserted Central Catheter (PICC)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of venous thrombosis
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Incidence of venous thrombosis defined as any new occurrence of symptomatic venous thrombosis defined by thrombus presence by ultrasonography or other imaging
|
from insertion though removal or 180 days, whichever comes first
|
Percent PICC remain in place through therapy
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Percent of PICCs that remain in place through the required therapy time period
|
from insertion though removal or 180 days, whichever comes first
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of phlebitis
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Incidence of phlebitis where phlebitis is defined inflammation of the cannulated vessel identified by redness, swelling, warmth, tenderness, and/or cord formation
|
from insertion though removal or 180 days, whichever comes first
|
Incidence of extravasation
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Incidence of extravasation where extravasation is defined as accidental infiltration of a vesicant or chemotherapeutic drug into the tissue around the catheter
|
from insertion though removal or 180 days, whichever comes first
|
Incidence of local infection
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Incidence of local infection where local infection is defined as presence of pus at the exit site and/or culture confirmed site infection
|
from insertion though removal or 180 days, whichever comes first
|
Incidence of Catheter-related bloodstream infection
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Incidence of Catheter-related bloodstream infection where Catheter-related bloodstream infection is defined as positive blood culture(s) with a microorganism not related to another source (e.g., UTI) OR positive blood culture(s) with microorganism matching catheter tip culture OR blood cultures from peripheral venous puncture and PICC positive with the same microorganism
|
from insertion though removal or 180 days, whichever comes first
|
Incidence of Accidental dislodgement
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Incidence of Accidental dislodgement where Accidental dislodgement is defined as catheter accidentally dislodged the extent to which it requires replacement
|
from insertion though removal or 180 days, whichever comes first
|
Incidence of vessel laceration
Time Frame: during the insertion procedure
|
Incidence of vessel laceration where vessel laceration is defined as a tear in the tissue of the vessel
|
during the insertion procedure
|
Incidence of vessel perforation
Time Frame: during the insertion procedure
|
Incidence of vessel perforation where vessel perforation is defined as a hole formed in the vessel
|
during the insertion procedure
|
Percent of patent catheters
Time Frame: from insertion though removal or 180 days, whichever comes first
|
Percent of patent catheters defined as the number of functional catheters through therapy/total number of catheters
|
from insertion though removal or 180 days, whichever comes first
|
Percent of placement success in single insertion attempt
Time Frame: during the insertion procedure
|
Percent of placement success in single insertion attempt defined as placement success defined as single insertion attempt, proper tip location, and patent catheter
|
during the insertion procedure
|
Ease of insertion
Time Frame: during the insertion procedure
|
Ease of insertion determined by composite score of guidewire/stylet performance based on post-insertion survey (5 point Likert scale)
|
during the insertion procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 18, 2020
Primary Completion (Actual)
January 31, 2022
Study Completion (Actual)
March 1, 2022
Study Registration Dates
First Submitted
February 7, 2020
First Submitted That Met QC Criteria
February 7, 2020
First Posted (Actual)
February 11, 2020
Study Record Updates
Last Update Posted (Actual)
March 21, 2022
Last Update Submitted That Met QC Criteria
March 17, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- MDS-19PICCEU01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripherally Inserted Central Catheter
-
TeleflexRecruitingPeripherally Inserted Central CatheterChina
-
University of ChicagoCompletedPeripherally Inserted Central Catheter Insertion TechniqueUnited States
-
Shandong Branden Med.Device Co.,LtdQilu Hospital of Shandong UniversityUnknownPeripherally Inserted Central CatheterChina
-
Pusan National University Yangsan HospitalCompletedPeripherally Inserted Central Catheter | Intravenous AccessKorea, Republic of
-
Yuan LingCompletedPeripherally Inserted Central Catheter | Intracavitary Electrocardiogram GuidingChina
-
University of PennsylvaniaRecruitingInsertion of Peripherally Inserted Central CatheterUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Antonio Maria Dell Anna; Sofia Cacciola; Claudio Sandroni; Giulia Chiuri; Mauro Pittiruti and other collaboratorsCompletedHemodynamic Monitoring | Peripherally Inserted Central Catheters | Centrally Inserted Central Catheter | Transpulmonary ThermodilutionItaly
-
Seattle Children's HospitalUniversity of WashingtonCompletedPeripherally Inserted Central CathetersUnited States
-
Medical University of South CarolinaWithdrawnPeripherally Inserted Central CathetersUnited States
-
TeleflexCompletedAdult Patients With Peripherally Inserted Central CathetersUnited States
Clinical Trials on Peripherally Inserted Central Catheter
-
Milton S. Hershey Medical CenterCompletedCentral Venous Catheter | Central Line | PICC | Neuro ICU | Neuroscience ICU | CVCUnited States
-
Pusan National University Yangsan HospitalCompletedPeripherally Inserted Central Catheter | Intravenous AccessKorea, Republic of
-
Medical College of WisconsinCompletedVascular Access Device ComplicationsUnited States
-
University of PittsburghNational Institutes of Health (NIH)CompletedCatheterizationUnited States
-
University of PittsburghNational Institutes of Health (NIH)CompletedCatheterizationUnited States
-
Saint George HospitalCompletedPain | Central Venous Catheter | Neonates
-
Hospital de Clinicas de Porto AlegreUnknownThrombosis | Infection
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownInfection | Thromboses, Venous | Economic ProblemsChina
-
InCor Heart InstituteUnknownCongestive Heart FailureBrazil
-
Children's Hospital of PhiladelphiaBoston Children's Hospital; Children's Hospital Medical Center, Cincinnati; University...CompletedPneumonia | Appendicitis | Osteomyelitis